-
Revealed: How SARS-CoV-2 evades our immune system
WorldPharmaNews
December 09, 2021
Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems.
-
Rogue antibodies wreak havoc in severe COVID-19 cases
worldpharmanews
May 21, 2021
The development of antibodies to the COVID-19 virus has been the great long-term hope of ending the pandemic. However, immune system turncoats are also major culprits in severe cases of COVID-19, Yale scientists report in the journal Nature.
-
Artificial intelligence model predicts which key of the immune system opens the locks of coronavirus
worldpharmanews
April 26, 2021
The human immune defense is based on the ability of white blood cells to accurately identify disease-causing pathogens and to initiate a defense reaction against them.
-
Virus uses ‘decoy’ strategy to evade immune system: Otago researchers
expresspharma
August 17, 2020
The research demonstrates another manner in which viruses are capable of hijacking infected cells and alerts scientists to the novel mechanism of viral transmission, say scientists.
-
Stanford study reveals immune-system deviations in severe COVID-19 cases
expresspharma
August 13, 2020
The study revealed, paradoxically, that the worse the case of COVID-19, the less effective certain cells of the innate immune system were in responding to the disease.
-
Researchers identify immune system variation linked to severe COVID-19 cases
expresspharma
July 29, 2020
The current study found that one risk factor was the presence of an immune system molecule called alpha interferon-a cytokine mobilised to combat viral pathogens such as the flu virus.
-
VitaDairy - the No. 1 colostrum company in Vietnam help people strengthening the immune system to contribute fighting off COVID-19
prnasia
July 20, 2020
Vietnam has been one of the countries that have well managed COVID-19 pandemic with only 383 cases, and no deaths have been reported (updated on 20th July). Immune Nutrition from ColosIgG 24h colostrum is one of the factors contribute fighting off COVID-1
-
Tocilizumab lowers risk of death for critical COVID-19 patients on ventilators, finds study
europeanpharmaceuticalreview
July 16, 2020
Patients who received tocilizumab in the retrospective, single-centre study were 45 percent less like to die and more likely to come off ventilation within 28 days.
-
Researchers identify six potential drug targets for COVID-19
expresspharma
June 28, 2020
The tumour necrosis factor, granzyme B, heat shock protein 70, interleukin-18, interferon-gamma-inducible protein 10, and elastase were found elevated in COVID-19 ICU patients.
-
MIS-C research can give insights on COVID-19 effect on immune system
expresspharma
June 22, 2020
As multisystem inflammatory syndrome in children due to COVID-19 resemble Kawasaki disease, there is a need for longitudinal studies to determine if similar long-term complications could emerge.